Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

被引：0
作者：
J. Palou
F. Pisano
R. Sylvester
S. Joniau
V. Serretta
S. Larré
S. Di Stasi
B. van Rhijn
A. J. Witjes
A. Grotenhuis
R. Colombo
A. Briganti
M. Babjuk
V. Soukup
P. U. Malmstrom
J. Irani
N. Malats
J. Baniel
R. Mano
T. Cai
E. K. Cha
P. Ardelt
J. Varkarakis
R. Bartoletti
G. Dalbagni
S. F. Shariat
E. Xylinas
R. J. Karnes
P. Gontero
机构：
[1] University of Barcelona,Department of Urology, Fundacio Puigvert
[2] Ospedale “Città della Salute e della Scienza-Molinette”,Dept of Urology
[3] Department of Biostatistics,Oncologic and Reconstructive Urology, Department of Urology
[4] EORTC Headquarters,Department of Surgical, Oncological and Stomatological Sciences
[5] University Hospitals Leuven,Department of Surgical Science, John Radcliffe Hospital
[6] University of Palermo,Department of Urology
[7] University of Oxford,Department of Urology
[8] Policlinico Tor Vergata-University of Rome,Dipartimento di Urologia
[9] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Urology, Motol Hospital
[10] Radboud University Nijmegen Medical Centre,Department of Urology, Academic Hospital
[11] Università Vita-Salute. Ospedale S. Raffaele,Department of Urology
[12] University of Praha,Genetic and Molecular Epidemiology Group
[13] Uppsala University,Department of Urology
[14] Centre Hospitalier Universitaire La Milétrie,Department of Urology
[15] University of Poitiers,Department of Urology
[16] Spanish National Cancer Research Centre (CNIO),Facharzt fur Urologie, Abteilung fur Urologie
[17] Rabin Medical Centre,Department of Urology, Sismanoglio Hospital
[18] Santa Chiara Hospital,Department of Experimental and Clinical Medicine
[19] Weill Medical College of Cornell University,Department of Urology
[20] Chirurgische Universitats klinik,Department of Urology
[21] University of Athens,Department of Urology
[22] University of Florence,undefined
[23] Memorial Sloan Kettering Cancer Center,undefined
[24] Medical University of Vienna,undefined
[25] Cochin Hospital,undefined
[26] Mayo Clinic,undefined
来源：
World Journal of Urology | 2018年 / 36卷
关键词：
Non-muscle invasive bladder cancer; Re-transurethral resection of the bladder; Recurrence; Progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1621 / 1627
页数：6
相关论文
共 70 条
  • [1] Svatek RS(2014)The economics of bladder cancer: costs and considerations of caring for this disease Eur Urol 66 253-262
  • [2] Hollenbeck BK(2013)Epidemiology and risk factors of urothelial bladder cancer Eur Urol 63 234-241
  • [3] Holmäng S(2017)EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016 Eur Urol 71 447-461
  • [4] Burger M(2006)Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 466-475
  • [5] Catto JWF(2009)Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette–Guerin: the CUETO scoring model J Urol 182 2195-2203
  • [6] Dalbagni G(2013)Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder Br J Cancer 109 1460-1466
  • [7] Babjuk M(2012)Restaging transurethral resection of bladder tumour for high-risk stage Ta and T1 bladder cancer Curr Urol Rep 13 109-114
  • [8] Böhle A(2014)Tumor stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer J Can Urol Assoc 8 6-10
  • [9] Burger M(2006)A re-staging transurethral resection predicts early progression of superficial bladder cancer BJU Int 97 1194-1198
  • [10] Sylvester RJ(2007)Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 177 75-79
1234567